Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes

Gene Cell Tissue. 2016 Apr;3(2):e35961. doi: 10.17795/gct-35961. Epub 2016 Feb 14.

Janella Hudson¹, Teresita Munoz-Antonia², Eric Haura^{3

4}, Doug Cress⁵, Vani N Simmons^{1

4}, Gwendolyn P Quinn^{1

4}

¹ Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States.
² Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States.
³ Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States.
⁴ Department of Oncologic Science, Morsani College of Medicine, University of South Florida, Tampa, United States.
⁵ Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States.

No abstract available

Keywords: EGFR Mutation; Genetic Testing; Genomic Targeted Therapy; Hispanics; Lung Cancer; Targeted Therapy.

Grants and funding